Bryan H. Bellaire

Dr. Bellaire's lab studies cellular interactions between pathogens and their hosts for a variety of emerging and zoonotic diseases. Current projects involve the development of novel antimicrobials to treat intracellular bacterial pathogens Tuberculosis and Meliodosis while reducing the amount of antibiotic resistance generated during therapy. Many of these approaches and techniques are analogous to developing therapies against viral infections, including Severe Acute Respiratory Syndrome (SARS)CoV2. Utilizing their knowledge of innate immunity and cellular microbiology, the lab will test the efficacy of existing FDA approved drugs repurposed for activity against SARSCoV2 using in vitro models of viral cytopathological effects and virus replication. Dr. Bellaire is a Registered Biosafety Professional and the BSL3 Laboratory Director for the College of Veterinary Medicine.